0
Zanidatamab with and without Tislelizumab in HER2-Positive Gastroesophageal Cancer. (nejm.org)
Authors:
Shitara K
… Shen L
Journal:
New England Journal of Medicine
Published:
2026-05-28
DOI:
https://doi.org/10.1056/NEJMoa2517729
Comments
Login to comment.
No comments yet. Be the first!